SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-028787
Filing Date
2023-06-20
Accepted
2023-06-20 08:45:24
Documents
13
Period of Report
2023-06-16
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alxo-20230616.htm   iXBRL 8-K 106808
2 EX-3.1 alxo-ex3_1.htm EX-3.1 359574
  Complete submission text file 0000950170-23-028787.txt   632113

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alxo-20230616.xsd EX-101.SCH 2473
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alxo-20230616_lab.xml EX-101.LAB 14166
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alxo-20230616_pre.xml EX-101.PRE 11011
7 EXTRACTED XBRL INSTANCE DOCUMENT alxo-20230616_htm.xml XML 4720
Mailing Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 231023518
SIC: 2834 Pharmaceutical Preparations